by Daniel X. Thomas
EP 3 103 443 B1 relates to the use of melatonin for the manufacture of a medicament for treating primary insomnia. EP 3 103 443 B1 results from a divisional application PCT/IL2002/000662 published under WO 2003/015690.
Brief outline of the case
The patent was revoked for lack of N over D15 of claim 1 as granted and of AR2-27.
by Daniel X. Thomas
EP 3 121 274 B1 relates to a method for predicting responsiveness to the treatment of cancer with a compound inhibiting p300.
Brief outline of the case
The patent was revoked for lack of sufficiency for the patent as granted as well as for AR1-7. AR8 was not admitted by the OD.
by Daniel X. Thomas
EP 3 049 439 B1 relates to bispecific polypeptides.
Brief outline of the case
The opposition was rejected and the opponent appealed.
The MR corresponds to the patent as granted.
The opponent did not attend the OP before the board, but maintained its written submissions.
In the statement of grounds of appeal the opponent referred to the notice of opposition,